Equity Capital Markets

Company · CIK 2075320

Polaryx Therapeutics, Inc.

CIK2075320 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inWY
Business addressNJ
ListedPLYX (Nasdaq)
First annual or quarterly report2026-03-24

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-291681
IPOFinal prospectus
 2025-11-212026-02-025

Filings

6
FiledFilingRegistrationAccession
2026-02-02424B4Final prospectus 333-2916810001213900-26-010761
2026-01-29EFFECTDeclared effective 333-2916819999999995-26-000339
2026-01-27S-1/AAmendment 333-2916810001213900-26-007973
2026-01-14S-1/AAmendment 333-2916810001213900-26-004079
2025-11-21S-1Registration filed 333-2916810001213900-25-113249
2025-08-05DRSDraft made public 377-082920001213900-25-072048

All filings of this company · CSV